Signatur Biosciences

Simple tests for complex diseases.

Y CombinatorSummer 2022ActiveHealthcareDiagnosticsBiotechHealthcareDiagnostics

What they do

Problem

Existing precision diagnostics that guide therapy decisions are slow and expensive because they require complex centralized lab facilities.

Solution

The company provides precision diagnostic tests (starting with breast cancer prognosis) designed to be run in local hospital labs to deliver faster, lower-cost results.

Who it's for

Hospital clinical laboratories and oncologists who need timely prognostic test results to guide breast cancer treatment decisions.

Founders

John Goertz

Founder

Co-founder, CSO, and PCRchitect at Signatur Biosciences. I teach machine learning to molecules to expand the range of diseases we can diagnose with PCR. NIH F32 Postdoctoral Fellow in the the Stevens Group at Imperial College London; PhD Bioengineering from University of Maryland, College Park; BSc Physics and Cell & Molecular Biology from Seattle University. When I’m not programming DNA, I’m cooking, running, or doing martial arts (Danzan-Ryu Japanese Jujitsu).

LinkedIn · X

Celestin de Wergifosse

Founder

Co-founder and CEO of Signatur Biosciences. Startups since the age of 14. First patent at 15. WIPO Best Young Inventor 2010. Twice TEDx speaker. Co-founded Young Change Maker, a social startup that highlights inspiring individuals. Co-founded and sold a company called Sauna en Bois. Bio-engineering from Imperial College London. When I don't work, I race motorcycles, climb or ski. My life-long goal is to develop biotech companies that address global issues.

LinkedIn · X